Why is Essential Tremor so Difficult to Treat? A Literature Review





Essential tremor (ET) is the most common movement disorder and affects tens of millions of individuals worldwide. It is characterized by isolated upper-limb tremors for at least three years without other neurological signs or tremors in other locations. Despite ET being a widespread movement disorder, its etiology and pathophysiology are poorly understood. This lack of understanding poses significant challenges towards the development of treatments and cures. There is no cure for ET, and current treatments for ET are limited and are often insufficient. ET symptoms can differ greatly between patients, and phenotyping is the only method for diagnosis. ET often overlaps with other disorders including dystonia and Parkinson’s disease, which further complicates diagnosis and treatment. Current treatments begin with pharmacotherapy, and progress to surgical options in drug-resistant patients. There is ongoing research into non-invasive electrical stimulation treatments that may prove to be safe and effective; however, further research is needed. The aim of this review is to assess the literature and summarize why ET is so difficult to treat. We evaluate the efficacy of current treatments, and the potential of future treatments. We summarize four reasons why ET remains so difficult to treat: 1) the unknown etiology and pathophysiology, 2) the lack of a suitable animal model, 3) difficulties with diagnosis, and 4) absence of personalized treatments. Despite the current challenges, ET remains an active area of research and novel experimental treatments may produce safe and effective non-invasive therapeutic options for ET.


Essential tremor, pathophysiology, treatment


Download data is not yet available.


T. Welton et al., “Essential tremor,” Nature Reviews Disease Primers, vol. 7, no. 1, pp. 1–17, Nov. 2021, doi: 10.1038/s41572-021-00314-w.

K. P. Bhatia et al., “Consensus Statement on the classification of tremors. from the task force on tremor of the International Parkinson and Movement Disorder Society,” Movement Disorders, vol. 33, no. 1, pp. 75–87, Jan. 2018, doi: 10.1002/MDS.27121.

E. D. Louis and M. McCreary, “How common is essential tremor? Update on the worldwide prevalence of essential tremor,” Tremor and Other Hyperkinetic Movements, vol. 11, no. 1, Jul. 2021, doi: 10.5334/tohm.632.

E. D. Louis and E. Louis, “The Roles of Age and Aging in Essential Tremor: An Epidemiological Perspective,” Neuroepidemiology, vol. 52, no. 1–2, pp. 111–118, Feb. 2019, doi: 10.1159/000492831.

J. S. Lou and J. Jankovic, “Essential tremor: Clinical correlates in 350 patients,” Neurology, vol. 41, no. 2 Part 1, pp. 234–234, Feb. 1991, doi: 10.1212/WNL.41.2_PART_1.234.

M. C. Sepúlveda Soto and A. Fasano, “Essential tremor: New advances,” Clin Park Relat Disord, vol. 3, p. 100031, Jan. 2020, doi: 10.1016/J.PRDOA.2019.100031.

N. I. Kremer et al., “Deep Brain Stimulation for Tremor: Update on Long-Term Outcomes, Target Considerations and Future Directions,” Journal of Clinical Medicine , vol. 10, no. 16, p. 3468, Aug. 2021, doi: 10.3390/JCM10163468.

J. Frey, C. W. Hess, L. Kugler, M. Wajid, and A. Wagle Shukla, “Transcranial Magnetic Stimulation in Tremor Syndromes: Pathophysiologic Insights and Therapeutic Role,” Front Neurol, vol. 12, p. 1482, Aug. 2021, doi: 10.3389/FNEUR.2021.700026

A. Karamesinis, R. v. Sillitoe, and A. Z. Kouzani, “Wearable Peripheral Electrical Stimulation Devices for the Reduction of Essential Tremor: A Review,” IEEE Access, vol. 9, pp. 80066–80076, 2021, doi: 10.1109/ACCESS.2021.3084819.

L. N. Clark and E. D. Louis, “Essential tremor,” in Handbook of Clinical Neurology, vol. 147, Elsevier, 2018, pp. 229–239. doi: 10.1016/B978-0-444-63233-3.00015-4.

R. J. Elble, “What is essential tremor? ,” Curr Neurol Neurosci Rep, vol. 13, no. 6, pp. 1–8, Jun. 2013, doi: 10.1007/S11910-013-0353-4

E. D. Louis et al., “Neuropathological changes in essential tremor: 33 cases compared with 21 controls,” Brain, vol. 130, no. 12, pp. 3297–3307, Dec. 2007, doi: 10.1093/BRAIN/AWM266.

A. M. Brown, J. J. White, M. E. van der Heijden, J. Zhou, T. Lin, and R. v. Sillitoe, “Purkinje cell misfiring generates high-amplitude action tremors that are corrected by cerebellar deep brain stimulation,” Elife, vol. 9, Mar. 2020, doi: 10.7554/ELIFE.51928.

B. Kosmowska and J. Wardas, “The Pathophysiology and Treatment of Essential Tremor: The Role of Adenosine and Dopamine Receptors in Animal Models,” Biomolecules , vol. 11, no. 12, p. 1813, Dec. 2021, doi: 10.3390/BIOM11121813.

Y. Buhidma, K. Rukavina, K. R. Chaudhuri, and S. Duty, “Potential of animal models for advancing the understanding and treatment of pain in Parkinson’s disease,” n p j Parkinson’s Disease , vol. 6, no. 1, pp. 1–7, Jan. 2020, doi: 10.1038/s41531-019-0104-6.

D. Haubenberger and M. Hallett, “Essential Tremor,” New England Journal of Medicine, vol. 378, no. 19, pp. 1802–1810, May 2018, doi: 10.1056/NEJMCP1707928.

M. A. Thenganatt and E. D. Louis, “Distinguishing essential tremor from Parkinson’s disease: bedside tests and laboratory evaluations,” Expert Review of Neurotherapeutics , vol. 12, no. 6, pp. 687–696, Jun. 2014, doi: 10.1586/ERN.12.49.

C. Y. Kim et al., “Repeated Spiral Drawings in Essential Tremor: a Possible Limb-Based Measure of Motor Learning,” The Cerebellum , vol. 18, no. 2, pp. 178–187, Apr. 2019, doi: 10.1007/S12311-018-0974-X

R. J. Elble, “The Essential Tremor Rating Assessment Scale,” J Neurol Neuromedicine, vol. 1, no. 4, pp. 34–38, 2016, Accessed: Feb. 15, 2023. [Online]. Available: https://www.jneurology.com/articles/the-essential-tremor-rating-assessment-scale.pdf

F. Holtbernd and N. J. Shah, “Imaging the Pathophysiology of Essential Tremor—A Systematic Review,” Front Neurol, vol. 12, p. 856, Jun. 2021, doi: 10.3389/fneur.2021.680254.

E. D. Louis, E. Rios, and C. Henchcliffe, “How are we doing with the treatment of essential tremor (ET)?,” Eur J Neurol, vol. 17, no. 6, pp. 882–884, Jun. 2010, doi: 10.1111/J.1468-1331.2009.02926.X.

Y. H. Liao, C. T. Hong, and T. W. Huang, “Botulinum Toxin for Essential Tremor and Hands Tremor in the Neurological Diseases: A Meta-Analysis of Randomized Controlled Trials,” Toxins (Basel), vol. 14, no. 3, p. 203, Mar. 2022, doi: 10.3390/TOXINS14030203.

S. O. Mittal, A. Lenka, and J. Jankovic, “Botulinum toxin for the treatment of tremor,” Parkinsonism Relat Disord, vol. 63, pp. 31–41, Jun. 2019, doi: 10.1016/j.parkreldis.2019.01.023.

G. Lu et al., “Outcomes and Adverse Effects of Deep Brain Stimulation on the Ventral Intermediate Nucleus in Patients with Essential Tremor,” Neural Plast, vol. 2020, 2020, doi: 10.1155/2020/2486065.

P. Wu et al., “Focused Ultrasound Thalamotomy for the Treatment of Essential Tremor: A 2-Year Outcome Study of Chinese People,” Front Aging Neurosci, vol. 13, p. 397, Jul. 2021, doi: 10.3389/FNAGI.2021.697029

T. R. Wang, R. F. Dallapiazza, S. Moosa, D. Huss, B. B. Shah, and W. J. Elias, Thalamic Deep Brain Stimulation Salvages Failed Focused Ultrasound Thalamotomy for Essential Tremor: A Case Report, vol. 96, no. 1. Karger Publishers, 2018, pp. 60–64. doi: 10.1159/000486646.

M. J. Wessel, L. R. Draaisma, and F. C. Hummel, “Mini-review: Transcranial Alternating Current Stimulation and the Cerebellum,” Cerebellum, vol. 22, no. 1, pp. 120–128, Feb. 2022, doi: 10.1007/S12311-021-01362-4




How to Cite

A. K. A. Dinh, A. J. Adeoti, and N. D. J. Strzalkowski, “Why is Essential Tremor so Difficult to Treat? A Literature Review”, Adv. J. Grad. Res., vol. 13, no. 1, pp. 29–36, Feb. 2023.